UÀÖ¹ú¼ÊÊ×Ò³

ƾ֤¡¶¹ã¶«Ê¡¿ÆѧÊÖÒÕÌü¹ØÓÚ2024Äê¶È¹ã¶«Ê¡¿ÆѧÊÖÒÕ½±ÌáÃûÊÂÇéµÄ֪ͨ¡·£¨ÔÁ¿Æº¯Çø×Ö¡²2024¡³1564ºÅ£©ÒªÇó£¬ÏÖ½«ÎÒµ¥Î»¼ÓÈë2024Äê¶È¹ã¶«Ê¡¿ÆѧÊÖÒÕ½±ÌáÃûÏîÄ¿ÓйØÄÚÈݾÙÐй«Ê¾£¬Ïê¼û¸½¼þ¡£ ¹«Ê¾Ê±¼ä£º2024Äê12ÔÂ27ÈÕÖÁ2025Äê1ÔÂ2ÈÕ£¬¹²7ÈÕ¡£ ¹«Ê¾Ê±´ú£¬Èç¶Ô¹«Ê¾ÄÚÈÝÓÐÒìÒ飬ÇëÒÔÊéÃæÐÎʽÏòÁªÏµÈË·´Ó¦¡£ÒÔСÎÒ˽¼ÒÃûÒå·´Ó¦ÇéÐεÄ£¬ÇëÌṩÕæʵÐÕÃû£¨²¢ÊðÃû£©¡¢ÁªÏµ·½·¨ºÍ·´Ó¦ÊÂÏîµÄ֤ʵÖÊÁϵÈ£»ÒÔµ¥Î»ÃûÒå·´Ó¦ÇéÐεÄ£¬ÇëÌṩµ¥Î»Ãû³Æ£¨²¢¼Ó¸Ç¹«Õ£©¡¢ÁªÏµÈË¡¢ÁªÏµ·½·¨ºÍ·´Ó¦ÊÂÏîµÄ֤ʵÖÊÁϵÈ¡£·²ÄäÃûÒìÒé¡¢Áè¼ÝÏÞÆÚÒìÒéµÄ²»ÓèÊÜÀí¡£ ÁªÏµÈË£ºÁõ±ÌºÃ ÁªÏµµç»°£º15876588034 °ì¹«ËùÔÚ£º¹ãÖÝÊÐÌìºÓÇøÍò¿ÆÔÆA¶°7Â¥ ¸½¼þ£º2024Äê¶È¹ã¶«Ê¡¿ÆѧÊÖÒÕ½±¹«Ê¾±í UÀÖ¹ú¼ÊÊ×Ò³2024Äê12ÔÂ27ÈÕ 2024Äê¶È¹ã¶«Ê¡¿ÆѧÊÖÒÕ½±¹«Ê¾±í£¨×ÔÈ»¿Æѧ½±¡¢ÊÖÒÕ·¢Ã÷½±¡¢¿Æ¼¼Ç°½ø½±¡¢¿Æ¼¼Ð§¹ûÍƹ㽱ÃûÌã© ѧ¿Æ¡¢×¨ÒµÆÀÉó×éÖÐÒ½ÓëÖÐҩѧרҵÆÀÉó×éÏîÄ¿Ãû³Æ»ùÓÚ&ldquo;Ö¤ÐÍ-°Ð±ê-ÁÆЧ&rdquo;µÄÖÐÒ½¾­·½ÂýÐÔÉöÔಡÑо¿ÏµÍ³¹¹½¨¼°Ó¦ÓÃÌáÃûÕ߹㶫ʡÖÐÒ½Ò©¾ÖÖ÷ÒªÍê³Éµ¥Î»¹ãÖÝÖÐÒ½Ò©´óѧɽ¶«´óѧÖ÷ÒªÍê³ÉÈË£¨Ö°³Æ¡¢Íê³Éµ¥Î»¡¢ÊÂÇ鵥룩1. ÖܾÁÑþ£¨½ÌÊÚ¡¢Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢ÊÂÇ鵥λ£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢Ö÷ҪТ˳£ºÏîÄ¿×ÜÈÏÕæÈË£¬Öƶ©×ÜÌåÑо¿Ë¼Ð÷ºÍ¼Æ»®£¬Í³³ï¿ÎÌâÉè¼ÆÓëʵÑ飩2. Ëï½ðÅô£¨Ñо¿Ô±¡¢Íê³Éµ¥Î»£ºÉ½¶«´óѧ¡¢ÊÂÇ鵥λ£ºÉ½¶«´óѧ¡¢Ö÷ҪТ˳£ºÈÏÕæGPCRɸѡÊÖÒÕƽ̨µÄ´î½¨ÓëÓ¦Óü°Ð§¹ûת»¯Íƹ㣩3. Îâ¿¡±ê£¨Ö÷ÈÎÖÐҩʦ¡¢Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢ÊÂÇ鵥λ£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢Ö÷ҪТ˳£ºÈÏÕæÉöÔ༲²¡»úÖÆÑо¿¼°Ð§¹ûת»¯Íƹ㣩4. Ñî·«£¨Ñо¿Ô±¡¢Íê³Éµ¥Î»£ºÉ½¶«´óѧ¡¢ÊÂÇ鵥λ£ºÉ½¶«´óѧ¡¢Ö÷ҪТ˳£ºÈÏÕæGPCRÖÐÒ½Ò©µÄɸѡ¼°Ð§¹ûת»¯Íƹ㣩5. Áº´ºÁᣨ¸±Ñо¿Ô±¡¢Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢ÊÂÇ鵥λ£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢Ö÷ҪТ˳£ºÈÏÕæÎÂÑôÀûË®ÖÎÁÆÂýÐÔÉöÔಡµÄÁÆЧÆÀ¼Û£©6. ÖÜÔ°£¨½ÌÊÚ¡¢Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢ÊÂÇ鵥λ£º¹ãÖÝÖÐÒ½Ò©´óѧ¡¢Ö÷ҪТ˳£ºÈÏÕæÕæÎäÌÀ¼°ÆäÓÐÓÃÒòËØÖÎÁÆÂýÐÔÉöÔಡµÄÁÆЧºÍ»úÖÆÑо¿£©7. ¹ùè´è´£¨Ñо¿Ô±¡¢Íê³Éµ¥Î»£ºÉ½¶«´óѧ¡¢ÊÂÇ鵥λ£ºÉ½¶«´óѧ¡¢Ö÷ҪТ˳£ºGPCRÖÐÒ½Ò©µÄɸѡÓëÅжÏÒÔ¼°GPCR°Ð±êÓëÉöÔ༲²¡µÄ¹ØÁªÆÊÎö£©8. Áõ±ÌºÃ£¨ÎÞ£¬Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ£¬ÊÂÇ鵥λ£ºUÀÖ¹ú¼ÊÊ×Ò³¡¢Ö÷ҪТ˳£ºÈÏÕæÂýÐÔÉöÔಡ»úÖÆÓëÒ©Îï×÷ÓÃÑо¿¼°Ð§¹ûת»¯Íƹ㣩9. ³Â¿¡÷裨Ö÷¹ÜÖÐҩʦ£¬Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ£¬ÊÂÇ鵥λ£ºÉîÛÚÊÐÖÐÒ½Ôº¡¢Ö÷ҪТ˳£ºÈÏÕæGPCR°Ð±êÔÚÂýÐÔÉöÔಡÖе÷¿Ø»úÖÆÑо¿£©10. ԬʥÁÁ£¨Ö÷¹Üҩʦ£¬Íê³Éµ¥Î»£º¹ãÖÝÖÐÒ½Ò©´óѧ£¬ÊÂÇ鵥λ£º¸ßÖÝÊÐÈËÃñÒ½Ôº¡¢Ö÷ҪТ˳£ºÈÏÕæÖÐÒ½¾­·½µÄҩЧÎïÖÊ»ù´¡Ñо¿£©´ú±íÐÔÂÛÎÄרÖøĿ¼ÂÛÎÄ1£º<Ãû³Æ: Structure of GPR101&ndash;Gs enables identification of ligands with rejuvenating potential¡¢ÆÚ¿¯£ºNature chemical biology¡¢Äê¾í£º2024,20¡¢½ÒÏþÈÕÆÚ£º2024.4¡¢µÚÒ»×÷ÕߣºZhao Yang¡¢Í¨Ñ¶×÷ÕߣºJin-Peng Sun>ÂÛÎÄ2£º<Ãû³Æ: Zhen-wu-tang ameliorates membranous nephropathy rats through inhibiting NF-&kappa;B pathway and NLRP3 inflammasome¡¢ÆÚ¿¯£ºPhytomedicine¡¢2019,59¡¢½ÒÏþÈÕÆÚ£º2019.4.2¡¢µÚÒ»×÷ÕߣºLiu Bihao¡¢Í¨Ñ¶×÷ÕߣºZhou Jiuyao >ÂÛÎÄ3£º<Ãû³Æ: Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPAR&gamma;/NF-&kappa;B pathway¡¢ÆÚ¿¯£ºBiomedicine pharmacotherapy¡¢Äê¾í£º2018, 101¡¢½ÒÏþÈÕÆÚ£º2018.5.22¡¢µÚÒ»×÷ÕߣºLiu Bihao¡¢Í¨Ñ¶×÷ÕߣºZhou Jiuyao >ÂÛÎÄ4£º<Ãû³Æ: Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang¡¢ÆÚ¿¯£ºFrontiers in Pharmacology¡¢Äê¾í£º2021, PMID: 33584283¡¢½ÒÏþÈÕÆÚ£º2021.1.27¡¢µÚÒ»×÷ÕߣºLi Jicheng¡¢Í¨Ñ¶×÷ÕߣºZhou Jiuyao>ÂÛÎÄ5£º<Ãû³Æ: Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy¡¢ÆÚ¿¯£ºPhytomedicine¡¢Äê¾í£º2023, 116¡¢½ÒÏþÈÕÆÚ£º2023.5.24¡¢µÚÒ»×÷ÕߣºYiwen Cao¡¢Í¨Ñ¶×÷ÕߣºZhou Jiuyao>֪ʶ²úȨÃû³ÆרÀû 1£º <ÇÊ°±´¼1Á×Ëá4ÊÜ Ì弤¶¯¼Á ¼°ÆäÓëÕæÎäÌÀÍŽáÔÚÖƱ¸ÖÎÁÆÂýÐÔÉöСÇòÉöÑ×Ò©ÎïÖеÄÓ¦ÓÃ>£¨ZL 202110678602. 2£¬ÖܾÁÑþ¡¢³Â¿¡÷è¡¢ÖÜÔ°¡¢Ëï½ðÅô¡¢Â¬ÈðÈðÎâãëçì¡¢¹ãÖÝÖÐÒ½Ò©´óѧ£¨¹ãÖÝÖÐÒ½Ò©Ñо¿Ôº£©£©